Budecort Inhaler
A budesonide inhaler for asthma and chronic obstructive pulmonary disease. It is a preventer, not a reliever, so it is used daily to reduce airway inflammation.
- Category
- Respiratory Health
- Active ingredient
- Budesonide
- Route
- Inhalation use
- Form
- Inhaler
- Strengths
- 100mcg · 200mcg
Prescription and consultation requirements for Budecort Inhaler vary by destination and are determined by the fulfilment partner.
Budecort Inhaler details
- Conditions
- Asthma · Chronic Obstructive Pulmonary Disease
- Alternative names
- budesonide
- Therapeutic class
- Glucocorticoid
- Pharmacological class
- Corticosteroid Inhaler
- Contraindications
- status asthmaticus; hypersensitivity to budesonide
- Minor side effects
- throat irritation; cough; hoarseness
- Moderate side effects
- oral thrush; headache; sinusitis
- Dosage forms
- Inhaler
- Administration route
- Inhalation use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Cipla Ltd
- Onset Time
- 1–2 weeks
- Duration
- 12 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Ketoconazole; Ritonavir
- Age restrictions
- Approved for children and adults.
Serious side effects
paradoxical bronchospasm, requires immediate medical attention; adrenal insufficiency, requires immediate medical attention
Patient summary
A budesonide inhaler for asthma and chronic obstructive pulmonary disease. It is a preventer, not a reliever, so it is used daily to reduce airway inflammation.
Mechanism of action
Suppresses mucosal inflammation and reduces airway wall thickness by inhibiting local cytokine and prostaglandin synthesis.
Pregnancy and breastfeeding
Pregnancy: Suitability during pregnancy depends on the specific medicine and individual circumstances. Confirm with a qualified clinician or pharmacist before use. Breastfeeding: Confirm breastfeeding suitability with a qualified clinician or pharmacist before use.